Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 195.00 190.00 200.00 195.00 195.00 195.00 5,718 07:49:55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 49.2 -56.5 -72.8 - 317

Amryt Pharma Share Discussion Threads

Showing 5126 to 5147 of 6075 messages
Chat Pages: Latest  207  206  205  204  203  202  201  200  199  198  197  196  Older
DateSubjectAuthorDiscuss
25/9/2019
10:49
He was very cagey about Nasdaq, must be close
alphabravo321
25/9/2019
10:19
New interview with Jo Wiley below Https://www.youtube.com/watch?v=GDRH35338W4
bermudashorts
25/9/2019
05:08
There you go again Papillon telling people yet again about your little top ups and when and at what price. You just repeat yourself. We don’t care what you do but you seem to think we really do. Do you think that we see you as a share guru? Papillon did this and that oh let’s copy him because after all he is the font of all share knowledge.
positivitynicholas
24/9/2019
23:45
Interesting, sidam. I presume that is why anyone who wanted to be absolutely certain of getting the CVR's, without any rigmarole, would have bought on Thursday 19th September, or before. Could that explain why the AMYT share price rose on Thursday 19th, but fell on Friday 20th? Of course this is all academic for me because I topped up twice in the days following relisting (105p & 107p) and again a week, or so, ago (124p). Only small top ups, but then I'm only poor!
papillon
24/9/2019
22:25
Delta The record date applies to the company’s register of members. If you are on the register on the record date you will be issued in this case the CVRs, but it could be a dividend. The fact that you are issued the CVRs does not mean that you are entitled to them, if you have already sold them, but you might be. The entitlement is subject to the date which the shares are quoted ex CVRs or dividend. These are often close together as the “market” does not want lots of claims being made. But they are not necessarily coterminous. The register if members does get electronically updated, but on settlement date not on the dealing date. If the shares were held in paper form, it might not be changed on the register for 10 or more days. Normal dealings are T2, which means the actual change on the share register occurs after two days not on the dealing day.
sidam
24/9/2019
21:37
"Only Scheme Shareholders entered in the register of members of the Company at the CVR Record Time, which on the current timetable is anticipated to be 8.00 p.m. on 20 September 2019, will be entitled to receive CVRs" Https://www.amrytpharma.com/wp-content/uploads/2019/09/Admission-Document-August-2019.pdf so if you sold on Friday, you will not have appeared on the register when it would've got updated at 8pm.
delta0091
24/9/2019
21:32
sidam.. no if someone sold on friday before close, they would NOT be entitled to the CVR. All holders that are on the register at 8pm on friday will be entitled. Think about it, if someone sold 20,000 on Friday, and another person bought those 20,000 there after - are you saying both sets of holders (and ex-holder) will get the CVRs ? Obviously not as that would mean issuing double the allowable CVRs. At 8pm the register would have got electronically updated - someone who sold on friday - or before, will not appear on there - someone who bought on friday and held on will appear on the register.
delta0091
24/9/2019
16:19
Regarding the CVR's, sidam this is what yesterday's RNS states. It's categoric and the OFFICIAL line! The NOMAD has authorised yesterday's RNS so it must be FACTUAL. So anyone who sold on, or before, Friday the 20th September will not be recorded as a shareholder/member at 8pm on the 20th September, which was the CVR record date. It's as plain as a pikestaff to me. Hence mdalos will NOT receive any CVR's! Here's the relevant extract copied from yesterday's RNS "Scheme Shareholders on Amryt's register of members at the CVR Record Time, which was 8.00 p.m. on 20 September 2019, will be entitled to receive three types of contingent value rights ("CVRs") in New Amryt for each Amryt Share held at that time"
papillon
24/9/2019
14:58
You are an annoying and antagonistic human being Papillon and yet some people defend you on here. Just read your last post winding someone up for the sheer hell of it. What a p
positivitynicholas
24/9/2019
12:08
baloo99 22 Sep '19 - 13:29 - 4963 of 4979 0 1 0 According to the Admission Document published on 27 August, the CVR record time was 8 pm on 20 September. Assuming that arrangement stands, only the shares that you still held on 20 September at 8 pm will be eligible for the CVRs. >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> The contents of baloo's post were confirmed by this extract from yesterday's RNS: "Scheme Shareholders on Amryt's register of members at the CVR Record Time, which was 8.00 p.m. on 20 September 2019, will be entitled to receive three types of contingent value rights ("CVRs") in New Amryt for each Amryt Share held at that time" >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> So you were wrong, mdalos. You will NOT hold any CVR's because you sold all of your AMYT shares on and before the 8pm 20th September deadline. I'm rather surprised we haven't heard from you recently. In fact you appear to have almost disappeared this week since are a prolific poster, but appear to have gone missing for the last few days only making one post yesterday on MIRL, according to your posting history.
papillon
23/9/2019
21:37
This is a "dead" thread, chica. I've given my answers to your questions on the "live" thread.
papillon
23/9/2019
18:33
Bye bye Amryt...hello New Amryt
alphabravo321
23/9/2019
17:50
You've just posted on an "obsolete" thread, chica. Here's your post. I've transferred it to this thread. chica1 23 Sep '19 - 16:26 - 123 of 123 0 0 0 Oh ok Thanks. How do they keep track of shares ownership? I have mine in my brokerage account. Another question What of the voucher Amryt gets if AP101 gets approval.If they sell it wouldn't be valued at a similar amount. >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> If you have your shares in a broker's nominee a/c your broker will just substitute the new shares for the old ones. No need to worry. They'll probably sell the voucher for the best price they can.
papillon
23/9/2019
16:26
Oh ok Thanks. How do they keep track of shares ownership? I have mine in my brokerage account. Another question What of the voucher Amryt gets if AP101 gets approval.If they sell it wouldn't be valued at a similar amount.
chica1
23/9/2019
16:26
Oh ok Thanks. How do they keep track of shares ownership? I have mine in my brokerage account. Another question What of the voucher Amryt gets if AP101 gets approval.If they sell it wouldn't be valued at a similar amount.
chica1
23/9/2019
15:33
Look at the RNS dated 27/8/2019, chica. Here's what it says about the CVR payments: "The CVRs are payable in three tranches, being: -- A contingent entitlement of up to a maximum amount of $35,000,000 subject to the Food & Drug Administration ("FDA") issuing a Qualifying Approval in respect of AP101 prior to 1 July 2022; -- A contingent entitlement of up to a maximum amount of $15,000,000 subject to the European Medicines Agency ("EMA") issuing a Qualifying Approval in respect of AP101 prior to 1 July 2022; and -- A contingent entitlement of up to a maximum amount of $35,000,000 on Amryt achieving a 12-Month Trailing Net Product Revenue in excess of $75,000,000 from sales of AP101 prior to 30 June 2024. If any such milestone is achieved, New Amryt may elect to pay the CVR Holders by the issue of New Amryt Shares or Loan Notes. If New Amryt elects to issue Loan Notes to CVR Holders, it will settle such loan notes in cash 120 days after their issue. If none of the milestones are achieved, Scheme Shareholders and Option holders will not receive any additional consideration under the terms of the CVRs. In these circumstances, the value of each CVR would be zero. The terms of the CVRs will be governed by the CVR Instrument, further details of which are set out in the Admission Document."
papillon
23/9/2019
14:55
What do the 3 CVR's in the New Amryt actually mean? Today's press release states. 'Amryt confirms that the Scheme Record Time will be 8.00 p.m. today, 23 September 2019. Scheme Shareholders on Amryt's register of members at the Scheme Record Time will, subject to the Scheme becoming effective, become entitled to receive New Amryt Shares pro rata to their existing holding at the Scheme Record Time. Furthermore, upon the Scheme becoming effective, Scheme Shareholders on Amryt's register of members at the CVR Record Time, which was 8.00 p.m. on 20 September 2019, will be entitled to receive three types of contingent value rights ("CVRs") in New Amryt for each Amryt Share held at that time. The CVRs are also being issued to Optionholders pro rata their existing holding of Options at the Scheme Record Time. Pursuant to the terms of the CVRs an aggregate amount of up to $85 million may become payable to the holders of CVRs if certain approvals and revenue milestones are met in relation to one of Amryt's principal clinical development products, AP101.
chica1
23/9/2019
14:46
Why do you have so many people on filter? Now take a wild guess 😂
positivitynicholas
23/9/2019
13:21
Tiananmen is another I have had on filter for a long time.
papillon
23/9/2019
13:19
I believe that this Aegerion deal, diamondstar, has turned my PURE PUNT on the outcome of the Phase III trial on AP101 into an INVESTMENT on the growth prospects of Juxtapid/Lojuxta and Myalept. Of course a successful outcome to the AP101 trial would be icing on the cake. Fingers crossed as always. Wiley and Nealon have, as Friel believes, pulled off a masterstroke in encouraging the creditors of Aegerion/Novelion to transfer a large chunk of that debt into new AMYT shares enabling a new start for Aegerion and in the process turning the old AMYT from a gamble on the success, or otherwise, of AP101 into a company that could withstand the failure of AP101 without it's share price being trashed in the process.
papillon
23/9/2019
12:10
Are we expecting much from this Court meeting starting in the next 10mins?
tiananmen
23/9/2019
11:08
Fair enough crack on 😂
positivitynicholas
Chat Pages: Latest  207  206  205  204  203  202  201  200  199  198  197  196  Older
ADVFN Advertorial
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200924 20:49:33